Date
22 August 2017

CSRC may scan IPO pricing of all listing candidates, paper says

The China Securities Regulatory Commission (CSRC) may send teams to examine the initial public offering (IPO) pricing of all the 51 applicants now in the queue, the 21st Century Business Herald reported Wednesday, citing unnamed sources. The move comes after the share flotation of Jiangsu Aosaikang Pharmaceutical Co. Ltd. (300361.CN) was halted due to high pricing. The CSRC previously said that it will conduct selective examination on pricing and marketing process of IPO applicants, according to the report.

– Contact HKEJ at [email protected]

KZ/AC/RC

EJI Weekly Newsletter

Please click here to unsubscribe